Blood Changes After Exercise in Restless Legs Syndrome
Launched by STANFORD UNIVERSITY · Jun 27, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how exercise affects the blood in people with Restless Legs Syndrome (RLS), a condition that causes uncomfortable sensations in the legs and an urge to move them. Researchers want to find out if exercising regularly changes certain proteins in the blood and how a single exercise session can impact these proteins. Participants in the study will be split into two groups: one group will exercise, while the other will not, for 12 weeks. Before and after the exercise, participants will take an exercise test and provide blood samples to help gather this information.
To join the study, you need to be at least 18 years old, have a diagnosis of moderate-to-severe RLS, and currently be inactive (not exercising regularly). You should also be able to walk without assistance. However, if you have other medical conditions that could mimic RLS or make exercise risky, you may not be eligible. If you decide to participate, you can expect to engage in an exercise program and help researchers learn more about RLS, which could lead to better treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age 18 years or older;
- • diagnosis of RLS;
- • presence of moderate-to-severe RLS (IRLS score\>15);
- • currently untreated RLS;
- • being non-active defined as not engaging in regular activity (30 minutes accumulated per day) on more than 2 days of the week during the previous six months;
- • ability to walk without assistance (does not use a cane/walker/wheelchair for mobility;
- • willing to complete outcome measures and complete the exercise program
- Exclusion Criteria:
- • present with a condition that can mimic RLS or cause secondary RLS (e.g., iron deficiency anemia, radiculopathy, peripheral edema, peripheral neuropathy, diabetes);
- • are at moderate or high risk for undertaking strenuous or maximal exercise
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Emmanuel Mignot, MD, PhD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported